RxDoctor Payments Data

Laci Ohare

Family · Clovis, NMNPI 1841861697

Payments from drug & device makers

$864in general payments, 2019–2025

Across 49 payments — averaging $17.63 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$165
  • Lilly USA, LLC$132
  • Novo Nordisk$131
  • Mylan Specialty L.p.$84
  • Pfizer$65
  • Exact Sciences$56
  • plus $231 from 8 others

What the payments were for

  • Food & beverage$864100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$864 in reported general payments places this provider in the 75th percentile of 1,080 family providers in New Mexico.

See all family providers in New Mexico

Medicare billing

Part B allowed, 2024
$61,762
Medicare patients
249
Services billed
1,315

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
FarxigaDapagliflozin Propanediol39$44,564
EliquisApixaban18$21,966
JanumetSitagliptin Phos/Metformin Hcl15$18,624
JardianceEmpagliflozin15$14,176
TrulicityDulaglutide11$14,087
OzempicSemaglutide17$13,864
JanuviaSitagliptin Phosphate18$13,785
Trelegy ElliptaFluticasone/Umeclidin/Vilanter19$11,828
Stiolto RespimatTiotropium Br/Olodaterol Hcl13$9,853
Lantus SolostarInsulin Glargine,hum.Rec.Anlog24$5,230
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen59$2,328
Albuterol Sulfate HfaAlbuterol Sulfate70$1,801
Diltiazem 24hr Er (Cd)Diltiazem Hcl14$1,403
Omeprazole57$1,013
Glipizide ErGlipizide24$1,012

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AstraZenecaFarxiga$32$44,56439 claims
PfizerEliquis$65$21,96618 claims
Lilly USA, LLCTrulicity$132$14,08711 claims
Novo NordiskOzempic$131$13,86417 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 1,080 family providers in New Mexico.

Other family in Clovis

See the full list for New Mexico

Where these figures come from

Is this you, or does something look wrong? →